Two Sigma Investments LP boosted its stake in shares of Cabot Corp (NYSE:CBT) by 167.7% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 192,433 shares of the specialty chemicals company’s stock after purchasing an additional 120,546 shares during the period. Two Sigma Investments LP owned 0.32% of Cabot worth $8,263,000 as of its most recent filing with the SEC.
Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. Bessemer Group Inc. grew its holdings in shares of Cabot by 575.7% during the third quarter. Bessemer Group Inc. now owns 2,034 shares of the specialty chemicals company’s stock worth $128,000 after buying an additional 1,733 shares in the last quarter. SG Americas Securities LLC grew its holdings in shares of Cabot by 135.1% during the third quarter. SG Americas Securities LLC now owns 42,023 shares of the specialty chemicals company’s stock worth $2,636,000 after buying an additional 24,148 shares in the last quarter. Prudential Financial Inc. grew its holdings in shares of Cabot by 304.1% during the third quarter. Prudential Financial Inc. now owns 274,307 shares of the specialty chemicals company’s stock worth $17,205,000 after buying an additional 206,430 shares in the last quarter. Commonwealth Bank of Australia bought a new position in shares of Cabot during the third quarter worth about $401,000. Finally, Bank of New York Mellon Corp grew its holdings in shares of Cabot by 26.0% during the third quarter. Bank of New York Mellon Corp now owns 3,355,240 shares of the specialty chemicals company’s stock worth $210,442,000 after buying an additional 691,985 shares in the last quarter. 86.62% of the stock is owned by institutional investors.
A number of research analysts recently issued reports on CBT shares. Zacks Investment Research downgraded Cabot from a “hold” rating to a “sell” rating in a report on Wednesday, January 16th. ValuEngine cut Cabot from a “sell” rating to a “strong sell” rating in a research report on Tuesday, February 5th. Finally, TheStreet raised Cabot from a “c” rating to a “b-” rating in a research report on Tuesday, February 5th. One research analyst has rated the stock with a sell rating, one has given a hold rating and four have issued a buy rating to the company. Cabot presently has an average rating of “Buy” and a consensus target price of $74.80.
Cabot (NYSE:CBT) last released its quarterly earnings data on Monday, February 4th. The specialty chemicals company reported $0.87 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.90 by ($0.03). Cabot had a net margin of 2.33% and a return on equity of 19.05%. The business had revenue of $821.00 million during the quarter, compared to analyst estimates of $778.50 million. During the same period in the previous year, the business earned $0.93 earnings per share. The business’s quarterly revenue was up 14.0% on a year-over-year basis. As a group, research analysts forecast that Cabot Corp will post 4.39 EPS for the current year.
COPYRIGHT VIOLATION WARNING: This article was first posted by Baseball Daily News and is owned by of Baseball Daily News. If you are accessing this article on another publication, it was illegally stolen and reposted in violation of U.S. and international trademark and copyright laws. The correct version of this article can be viewed at https://www.baseballdailydigest.com/news/2019/04/15/two-sigma-investments-lp-has-8-26-million-holdings-in-cabot-corp-cbt.html.
Cabot Corporation operates as a specialty chemicals and performance materials company. The company offers rubber grade carbon blacks used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and compounds of carbon black and rubber.
Recommended Story: What are retained earnings?
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.